ClinicalThought: MCL Management

Share

Program Content

Activities

  • Optimizing Induction for MCL
    My Thoughts on Optimizing Induction Therapy for MCL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 30, 2018

    Expires: April 29, 2019

  • MCL: BTK Inhibitors
    MCL at First Relapse: Selecting a First- vs Second-Generation BTK Inhibitor
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 10, 2018

    Expires: August 09, 2019

Faculty

cover img faculity

Christopher R. Flowers, MD, MS

Department Chair
Department of Lymphoma/Myeloma, Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Julie M. Vose, MD

Neumann M. and Mildred E. Harris Professor
Chief
, Section of Hematology/Oncology
Professor of Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Provided by

ProCE Banner

Supporters

AbbVie

AstraZeneca Pharmaceuticals

Pharmacyclics Inc